PhaseI/II study of TS-1+CDDP in combination with Radiotherapy with unresectable and locally advanced for biliary tract cancer.
Phase of Trial: Phase I/II
Latest Information Update: 12 May 2016
At a glance
- Drugs Cisplatin (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Adenocarcinoma; Bile duct diseases; Biliary cancer; Gallbladder cancer
- Focus Adverse reactions; Therapeutic Use
- 13 Mar 2012 New trial record